{"id":"W4402560614","doi":"10.1016/j.annonc.2024.08.1481","title":"1415P Real-world data on the use of nivolumab plus chemotherapy for patients with metastatic GC/GEJC/EAC: A Canadian perspective","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Mount Sinai Hospital; Bristol-Myers Squibb (Canada); Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; Capital District Health Authority; Centre Hospitalier de l’Université de Montréal","funders":"Pfizer","keywords":"Medicine; Nivolumab; Oncology; Chemotherapy; Perspective (graphical); Internal medicine; Cancer; Immunotherapy; Artificial intelligence","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006922776,0.000735111,0.001757971,0.002677693,0.001455164,0.003850249,0.002073244,0.001445651,0.01614697],"category_scores_gemma":[0.02747572,0.0005719401,0.002217063,0.01157378,0.001298697,0.001400973,0.001085765,0.00360699,0.001920646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03423673,"about_ca_system_score_gemma":0.08032724,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9582903,"about_ca_topic_score_gemma":0.9720613,"domain_scores_codex":[0.993575,0.001284315,0.0007665084,0.0007173599,0.002748962,0.0009077225],"domain_scores_gemma":[0.9444557,0.01010553,0.007902785,0.001536058,0.03180944,0.004190409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.003872515,0.0001879866,0.206985,0.00766014,0.003715229,0.0006157734,0.000740699,0.006027621,0.001273394,0.01611285,0.5524432,0.2003655],"study_design_scores_gemma":[0.001360097,0.000474781,0.4126743,0.01019979,0.003305756,0.0007183393,0.00160245,0.002045541,0.0005453399,0.004960631,0.5617178,0.0003951733],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"empirical","genre_scores_codex":[0.05406167,0.1307422,0.003444043,0.2525961,0.0043076,0.0003518984,0.4340678,0.000426423,0.1200024],"genre_scores_gemma":[0.5125907,0.1311771,0.01533703,0.1021002,0.007518785,0.0004482398,0.2181245,0.0006870261,0.01201655],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.04170966,"threshold_uncertainty_score":0.248406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1921316380717326,"score_gpt":0.4135616564876052,"score_spread":0.2214300184158727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}